{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:18:49Z","timestamp":1787678329001,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP20ek0210154"],"award-info":[{"award-number":["JP20ek0210154"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.thromres.2026.109754","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T23:06:59Z","timestamp":1781737619000},"page":"109754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cytochalasins modulate donor responsiveness in functional assays for heparin-induced thrombocytopenia"],"prefix":"10.1016","volume":"264","author":[{"given":"Minghai","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Yasumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Usami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanao","family":"Hatase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Ieko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Teshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2026.109754_bb0005","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1182\/blood-2013-01-477091","article-title":"Critical role for mouse marginal zone B cells in PF4\/heparin antibody production","volume":"121","author":"Zheng","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109754_bb0010","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1182\/blood.V98.8.2442","article-title":"Heparin-induced thrombocytopenia\/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through Fc\u03b3RIIA","volume":"98","author":"Reilly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109754_bb0015","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood.V72.3.925.bloodjournal723925","article-title":"Heparin-induced thrombocytopenia: laboratory studies","volume":"72","author":"Kelton","year":"1988","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109754_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1160\/TH04-12-0825","article-title":"Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis: a retrospective analysis of 408 patients","volume":"94","author":"Greinacher","year":"2005","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109754_bb0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-8652(199709)56:1<12::AID-AJH3>3.0.CO;2-5","article-title":"Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution","volume":"56","author":"Nand","year":"1997","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2026.109754_bb0030","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1182\/blood-2015-07-661215","article-title":"Diagnostic value of immunoassays for heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"127","author":"Nagler","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109754_bb0035","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.24006","article-title":"The platelet serotonin-release assay","volume":"90","author":"Warkentin","year":"2015","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2026.109754_bb0040","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0038-1646493","article-title":"A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia","volume":"66","author":"Greinacher","year":"1991","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109754_bb0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.chest.2016.02.641","article-title":"A novel PF4-dependent platelet activation assay identifies patients likely to have heparin-induced thrombocytopenia\/thrombosis","volume":"150","author":"Padmanabhan","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2026.109754_bb0050","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1046\/j.1365-2141.1996.d01-1944.x","article-title":"A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry","volume":"95","author":"Lee","year":"1996","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2026.109754_bb0055","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1160\/TH16-06-0482","article-title":"Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry","volume":"117","author":"Maeda","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109754_bb0060","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3390\/jcm9041226","article-title":"Detection of platelet-activating antibodies associated with heparin-induced thrombocytopenia","volume":"9","author":"Tardy","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2026.109754_bb0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1083\/jcb.92.1.69","article-title":"Correlation between effects of 24 different cytochalasins on cellular structures and cellular events and those on actin in vitro","volume":"92","author":"Yahara","year":"1982","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.thromres.2026.109754_bb0070","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood.V81.6.1505.1505","article-title":"Membrane glycoproteins and platelet cytoskeleton in immune complex-induced platelet activation","volume":"81","author":"Kang","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109754_bb0075","doi-asserted-by":"crossref","first-page":"5400","DOI":"10.1016\/S0021-9258(18)83559-1","article-title":"Possible involvement of cytoskeleton in collagen-stimulated activation of phospholipases in human platelets","volume":"264","author":"Nakano","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2026.109754_bb0080","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1182\/blood-2004-04-1392","article-title":"The actin cytoskeleton differentially regulates platelet \u03b1-granule and dense-granule secretion","volume":"105","author":"Flaumenhaft","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109754_bb0085","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.3390\/cells11101615","article-title":"Cytoskeleton dependent mobility dynamics of Fc\u03b3RIIA facilitates platelet haptotaxis and capture of opsonized bacteria","volume":"11","author":"Palankar","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.thromres.2026.109754_bb0090","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/09537100020027842","article-title":"Effects of cytochalasin H, a potent inhibitor of cytoskeletal reorganization, on platelet function","volume":"11","author":"Natarajan","year":"2000","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2026.109754_bb0095","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1152\/physiol.00020.2016","article-title":"New concepts and mechanisms of platelet activation signaling","volume":"32","author":"Estevez","year":"2017","journal-title":"Physiology"},{"key":"10.1016\/j.thromres.2026.109754_bb0100","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.0402111101","article-title":"An enantioselective, modular, and general route to the cytochalasins: synthesis of L-696,474 and cytochalasin B","volume":"101","author":"Haidle","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.thromres.2026.109754_bb0105","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1083\/jcb.105.4.1473","article-title":"Effects of Cytochalasin and Phalloidin on Actin","volume":"105","author":"Cooper","year":"1987","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.thromres.2026.109754_bb0110","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0008-8749(90)90041-O","article-title":"Characterization of the Fc\u03b3 receptor on human platelets","volume":"128","author":"King","year":"1990","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.thromres.2026.109754_bb0115","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.devcel.2014.04.031","article-title":"Actin cytoskeleton reorganization by Syk regulates Fc\u03b3 receptor responsiveness by increasing its lateral mobility and clustering","volume":"29","author":"Jaumouill\u00e9","year":"2014","journal-title":"Dev. Cell"},{"key":"10.1016\/j.thromres.2026.109754_bb0120","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/09537100701777303","article-title":"Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin \u03b12\u03b21","volume":"19","author":"Pula","year":"2008","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2026.109754_bb0125","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/09537104.2020.1859103","article-title":"Platelet calcium signaling by G-protein coupled and ITAM-linked receptors regulating anoctamin-6 and procoagulant activity","volume":"32","author":"Fern\u00e1ndez","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.thromres.2026.109754_bb0130","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1182\/blood-2017-02-764670","article-title":"CLEC-2\/podoplanin and thromboinflammation","volume":"129","author":"Suzuki-Inoue","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109754_bb0135","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1074\/jbc.M112.424473","article-title":"Fucoidan is a novel platelet agonist for the C-type lectin-like receptor 2 (CLEC-2)","volume":"288","author":"Manne","year":"2013","journal-title":"J. Biol. Chem."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:28:16Z","timestamp":1787675296000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826001738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"alternative-id":["S0049384826001738"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109754","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytochalasins modulate donor responsiveness in functional assays for heparin-induced thrombocytopenia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109754","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109754"}}